Exemestane (Trade name: Aromasin®) is an oral steroidal aromatase inhibitor used in the treatment of hormonally-responsive breast cancer.

Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Exemestane selectively targets and irreversibly binds to the aromatase enzyme, thereby inhibiting the production of estrogen.

The estrogen suppression rate for Exemestane is 85%.

More on [ Exemestane ]

Exemestane - Twitter Search

Breast cancer regimen 'raises carpal tunnel risk': Researchers said 2.8% of the exemestane group suffered carpal... http://t.co/HHU6LeYF
carpalcure (damian k) Tue, 24 Jan 2012 10:49:53 -0000
Breast cancer regimen 'raises carpal tunnel risk': Researchers said 2.8% of the exemestane group suffered carpal... http://t.co/HHU6LeYF
HER2-negative #breastcancer patient? #Oncologist Jose Baselga from @MassGeneralNews comes to #thegrouproom http://t.co/mW1aY0dg
vitaloptions (Terry Wilcox) Tue, 24 Jan 2012 07:58:18 -0000
HER2-negative #breastcancer patient? #Oncologist Jose Baselga from @MassGeneralNews comes to #thegrouproom http://t.co/mW1aY0dg
All peptides tadalaf Subscribe to Exemestane RSS feed